Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome

Liver Transplantation

Volumn 12, Issue 8, 2006, Pages 1244-1252

  Pungpapong, Surakit ^a   Alvarez, Salvador ^a   Hellinger, Walter C ^a   Kramer, David J ^a   Willingham, Darrin L ^a   Mendez, Julio C ^a   Nguyen, Justin H ^a   Hewitt, Winston R ^a   Aranda Michel, Jaime ^a   Harnois, Denise M ^a   Rosser, Barry G ^a   Hughes, Christopher B ^a   Grewal, Hani P ^a   Satyanarayana, Raj ^a   Dickson, Rolland C ^a   Steers, Jeffrey L ^a   Keaveny, Andrew P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL BLEEDING; ADULT; AGE; ARTICLE; ASCITES FLUID; BACTERIUM CULTURE; BACTERIUM ISOLATION; BILIARY TRACT DISEASE; BILIARY TRACT SURGERY; CADAVER DONOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FUNGUS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; INFECTION COMPLICATION; INTESTINE PERFORATION; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; NONHUMAN; OPERATION DURATION; OUTCOME ASSESSMENT; PERITONITIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ROUX Y ANASTOMOSIS; SCORING SYSTEM; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

ASCITIC FLUID; HUMANS; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PERITONITIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33746931273     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20801     Document Type: Article

References (19)

1. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-1654.
2. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004;39:841-856.
3. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-674; quiz 675-666.
4. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002;35: 140-148.
5. Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol 2005;42(suppl):S85-S92
6. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341: 403-409.
7. Garcia-Tsao G. Spontaneous bacterial peritonitis: a historical perspective. J Hepatol 2004;41:522-527.
8. Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990;98: 127-133.
9. Runyon BA, Such J. Surgical peritonitis and other diseases of the peritoneum, mesentery, omentum, and diaphragm. In: Feldman M, Friedman LS, Sleisenger MH eds. Gastrointestinal and Liver Disease. Vol. 2. 7th ed. Philadelphia: Saunders, 2002;2357-2350.
10. Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastro-intestinal tract perforation into ascitic fluid. Hepatology 1984;4:447-450.
11. Runyon BA. Bacterial peritonitis secondary to a perinephric abscess. Case report and differentiation from spontaneous bacterial peritonitis. Am J Med 1986;80:997-998.
12. George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, Whitington PF, et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991: 13:387-396.
13. Rosser B, Mai M, Kramer D, Grewal H, Satyanarayana R, Keaveny A, et al. Interleukin-2 receptor alpha sub-unit antibody therapy allows delayed introduction of calcineurin-inhibitor based immunosuppression in liver transplant patients with perioperative renal impairment [abstract]. Am J Transplant 2004;4:367.
14. Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, et al. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl 2005; 11:656-662.
15. Brook I, Frazier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000;49:827-830.
16. Lorber B, Swenson RM. The bacteriology of intra-abdominal infections. Surg Clin North Am 1975;55: 1349-1354.
17. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25: 107-131.
18. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001; 7: 22-26.
19. Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000;31:545-553.